| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Depth of remission is a prognostic factor for survival in patients with metastatic renal cell carcinoma. | Eur Urol | 2015 | 0.84 |
| 2 | Efficacy and safety of gemcitabine, oxaliplatin, and paclitaxel in cisplatin-refractory germ cell cancer in routine care-Registry data from an outcomes research project of the German Testicular Cancer Study Group. | Urol Oncol | 2015 | 0.75 |